Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

CSE/GWAY stock hub

CSE/GWAY has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CSE/GWAYis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

21.3M

Canadian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

CSE/GWAY

In the news

Latest news · CSE/GWAY

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11P50 15.6P75 25.4

Trailing P/En/a

P25 7.4P50 15.6P75 34.3

ROE-2.2

P25 -121.5P50 -40.9P75 0.5

ROIC2.2

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CSE/GWAY market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

169

Groups with data

Currency

CAD

Showing 169 of 169 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Employees Change	1%
Employees Change Percent	11.11
Enterprise value	CAD 35.8M
Exchange	Canadian Securities Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CA39679F2035
Last refreshed	2026-05-10
Market cap	CAD 21.3M
Price	CAD 0.16
Price currency	CAD
Sector	Healthcare
Sic	2834
Symbol	cse/GWAY
Website	https://www.greenway.ca

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-1%
EV Earnings	-167.81x
EV/EBIT	40.41x
EV/EBITDA	15.7x
EV/FCF	-36.65x
EV/Sales	3.92x
FCF yield	-4.58%
P/B ratio	2.17x
P/S ratio	2.33x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	9.69%
EBITDA Margin	18.97%
Gross margin	51.07%
Gross Profit	CAD 4.7M
Gross Profit Growth	191.82%
Gross Profit Growth Q	68.79%
Gross Profit Growth3 Y	21.46%
Net Income	CAD -213,133
Net Income Growth Quarters	5%
Net Income Growth Years	1%
Pretax Margin	-2.33%
Profit Margin	-2.33%
ROA	1.72
Roa5y	-3.97
ROCE	4.4
ROE	-2.18
Roe5y	-20.94
ROIC	2.17

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-20.01%
Cagr3y	-11.39%
EPS Growth Quarters	5
EPS Growth Years	1
Revenue Growth	24.1x
Revenue Growth Q	40.08x
Revenue Growth Quarters	2x
Revenue Growth Years	1x
Revenue Growth3 Y	25.86x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 0.28
Assets	CAD 32.6M
Cash	CAD 1.2M
Current Assets	CAD 7.4M
Current Liabilities	CAD 12.5M
Debt	CAD 15.6M
Debt EBITDA	CAD 6.86
Debt Equity	CAD 1.59
Debt FCF	CAD -16.01
Equity	CAD 9.8M
Interest Coverage	0.81
Liabilities	CAD 22.8M
Long Term Assets	CAD 25.3M
Long Term Liabilities	CAD 10.3M
Net Cash	CAD -14.4M
Net Cash By Market Cap	CAD -67.76
Net Debt EBITDA	CAD 8.34
Net Debt Equity	CAD 1.47
Tangible Book Value	CAD 9.8M
Tangible Book Value Per Share	CAD 0.07
WACC	5.25

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.59
Inventory Turnover	1.64
Net Working Capital	CAD -1M
Quick ratio	0.2
Working Capital	CAD -5.1M
Working Capital Turnover	CAD -2.63

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.54%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-20%
200-day SMA	0.19
3Y total return	-30.43%
50-day SMA	0.16
50-day SMA vs 200-day SMA	50under200
All Time High	1.8
All Time High Change	-91.11%
All Time High Date	2021-11-18
All Time Low	0.12
All Time Low Change	33.33%
All Time Low Date	2025-11-05
ATR	0.01
Beta	0.14
Beta1y	0.84
Beta2y	0.72
Ch YTD	-11.11
High	0.16
High52	0.3
High52 Date	2025-07-25
High52ch	-46.67%
Low	0.16
Low52	0.12
Low52 Date	2025-11-05
Low52ch	33.33%
Ma50ch	-0.62%
Price vs 200-day SMA	-14.21%
RSI	50.16
RSI Monthly	42.57
RSI Weekly	46.53
Sharpe ratio	-0.14x
Sortino ratio	-0.15
Total Return	-0.54%
Tr YTD	-11.11
Tr1m	-5.88%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD 885,005
Operating margin	9.69

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	33,181,907%
Shares Insiders	0.05%
Shares Out	133,247,074
Shares Qo Q	0%
Shares Yo Y	0.54%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CAD -1.2M
Average Volume	7,768.7x
Bv Per Share	0.07
CAPEX	CAD -196,134
Ch1m	-5.88
Ch1y	-20
Ch3y	-30.43
Ch6m	-3.03
Change	6.67%
Change From Open	0
Close	0.15
Days Gap	6.67
Depreciation Amortization	847,368
Dollar Volume	323
Earnings Date	2026-06-11
EBIT	CAD 885,005
EBITDA	CAD 1.7M
EPS	CAD -0
F Score	4
FCF	CAD -975,906
FCF EV Yield	-2.73x
FCF Per Share	CAD -0.01
Fiscal Year End	March
Founded	2,018
Investing CF	-196,134
Is Primary Listing	1
Last Earnings Date	2026-02-27
Last Report Date	2025-12-31
Ma150	0.18
Ma150ch	-11.99%
Ma20	0.16
Ma20ch	1.91%
Net CF	-975,906
Next Earnings Date	2026-06-11
Open	0.16
Ppne	25,273,679
Price Date	2026-05-08
Price EBITDA	CAD 12.31
Ptbv Ratio	2.17
Relative Volume	0.26x
Revenue	9,133,634x
SBC By Revenue	2.96x
Share Based Comp	270,013
Tr6m	-3.03%
Volume	2,019
Z Score	0.06

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CSE/GWAY pay a dividend?

Capital-return profile for this ticker.

Performance

CSE/GWAY stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CSE/GWAY?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+0.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.5%

Negative means the company is buying back shares.

Technical

CSE/GWAY momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

50.2

Neutral momentum band

Price vs 200-day MA

-14.2%

50/200-day relationship not available

Beta (5Y)

0.14

Less volatile than the market

Sharpe ratio

-0.14

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CSE/GWAY

Hub-level FAQ points readers to the deeper analysis pages.

What is the current cse/GWAY stock rating?

cse/GWAY is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full cse/GWAY analysis?

The full report lives at /stocks/cse/GWAY/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for cse/GWAY?

The latest report frames cse/GWAY around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the cse/GWAY page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.